CSIMarket
 


Rich Pharmaceuticals, Inc.  (RCHA)
Other Ticker:  
 
 

RCHA's Operating Income Growth by Quarter and Year

Rich Pharmaceuticals,'s Operating Income results by quarter and year




RCHA Operating Income (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter March -0.31 -0.34 -0.26 -1.21
III Quarter December -0.33 -0.21 -0.30 -1.36
II Quarter September -0.22 -0.18 -0.23 -0.52
I Quarter June -0.47 -0.22 -0.33 -0.52
FY   -1.33 -0.95 -1.12 -3.61



RCHA Operating Income fourth quarter 2018 Y/Y Growth Comment
Rich Pharmaceuticals, Inc. in the fourth quarter 2018 recorded Operating Loss of $ -0.31 millions.

According to the results reported in the fourth quarter 2018, Rich Pharmaceuticals, Inc. achieved the best Operating Income growth in Biotechnology & Pharmaceuticals industry. While Rich Pharmaceuticals, Inc.' s Operating Income no change of % ranks overall at the positon no. in the fourth quarter 2018.

Explain Operating Income growth


RCHA Operating Income ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter March - - - -
III Quarter December - - - -
II Quarter September - - - -
I Quarter June - - - -
FY   - - - -

Financial Statements
Rich Pharmaceuticals,'s fourth quarter 2018 Operating Income $ -0.31 millions RCHA's Income Statement
Rich Pharmaceuticals,'s fourth quarter 2017 Operating Income $ -0.34 millions Quarterly RCHA's Income Statement
New: More RCHA's historic Operating Income Growth >>


RCHA Operating Income (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter March - - - -
III Quarter December - - - -
II Quarter September - - - -
I Quarter June - - - -
FY (Year on Year)   - - - -




Operating Income fourth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income fourth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Rich Pharmaceuticals,'s Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RCHA's IV. Quarter Q/Q Operating Income Comment
Even if Rich Pharmaceuticals, Inc. in the IV. Quarter 2018 admitted Operating Loss of $ -0.31 millions, it should be said, that those numbers point to improvement compare to the -0.33 millions in the third quarter.

Within Biotechnology & Pharmaceuticals industry Rich Pharmaceuticals, Inc. achieved highest sequential Operating Income growth. While Rich Pharmaceuticals,'s Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RCHA's IV. Quarter Q/Q Operating Income Comment
Despite the fact, that Rich Pharmaceuticals, Inc. in the IV. Quarter 2018 admitted Operating Loss of $ -0.31 millions, some analyst point out, that those numbers are slight up side relative to the -0.33 millions in the third quarter.

Within Biotechnology & Pharmaceuticals industry Rich Pharmaceuticals, Inc. achieved highest sequential Operating Income growth. While Rich Pharmaceuticals,'s Operating Income growth quarter on quarter, overall rank is .


Rich Pharmaceuticals,'s 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
12 Months Ending
(Jun 30 2017)
12 Months Ending
(Mar 31 2017)
Cumulative Operating Income 12 Months Ending $ -1.34 $ -1.37 $ -1.24 $ -1.21 $ -0.95
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Rich Pharmaceuticals, Inc.' has realized cumulative trailing twelve months Operating Loss of $ -1 millions in the Mar 31 2018 period.

Rich Pharmaceuticals, Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Rich Pharmaceuticals, Inc.' has realized cumulative trailing twelve months Operating Loss of $ -1 millions in the Mar 31 2018 period.

Rich Pharmaceuticals, Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Pharmaceuticals Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
RCHA's Operating Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for RCHA's Competitors
Operating Income Growth for Rich Pharmaceuticals,'s Suppliers
Operating Income Growth for RCHA's Customers

You may also want to know
RCHA's Annual Growth Rates RCHA's Profitability Ratios RCHA's Asset Turnover Ratio RCHA's Dividend Growth
RCHA's Roe RCHA's Valuation Ratios RCHA's Financial Strength Ratios RCHA's Dividend Payout Ratio
RCHA's Roa RCHA's Inventory Turnover Ratio RCHA's Growth Rates RCHA's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Mar 31 2018 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2018
Surgery Partners Inc -1.34%$ -1.337 millions
Pediatrix Medical Group Inc -1.51%$ -1.513 millions
Carlisle Companies Incorporated-2.07%$ -2.068 millions
Quest Diagnostics Inc-2.51%$ -2.509 millions
Biospecifics Technologies Corp-3.70%$ -3.704 millions
Universal Health Services Inc -5.68%$ -5.684 millions
Enovis Corporation-6.11%$ -6.114 millions
Laboratory Corporation Of America Holdings-8.21%$ -8.206 millions
National Research Corporation-10.28%$ -10.276 millions
Phibro Animal Health Corporation-11.62%$ -11.617 millions
West Pharmaceutical Services Inc -12.89%$ -12.887 millions
Zimmer Biomet Holdings Inc -12.96%$ -12.957 millions
Edwards Lifesciences Corporation-15.35%$ -15.354 millions
Psychemedics Corp-15.96%$ -15.961 millions
Dentsply Sirona Inc -18.41%$ -18.409 millions
Protokinetix Incorporated-18.67%$ -18.674 millions
Ufp Technologies Inc -20.00%$ -20.000 millions
Lannett Company Inc-23.73%$ -23.734 millions
Glucotrack Inc -26.53%$ -26.535 millions
Fonar Corporation-26.66%$ -26.658 millions
Hill rom Holdings Inc -27.52%$ -27.516 millions
Mylan N v -31.47%$ -31.470 millions
Owens and Minor inc-31.82%$ -31.816 millions
Livanova Plc-32.69%$ -32.685 millions
Heska Corporation-32.89%$ -32.891 millions
China Yct International Group, Inc.-33.19%$ -33.186 millions
Addus Homecare Corporation-34.48%$ -34.478 millions
U s Neurosurgical Holdings Inc -34.89%$ -34.891 millions
Jazz Pharmaceuticals Plc-35.50%$ -35.502 millions
Alpha Pro Tech Ltd -35.74%$ -35.736 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com